MCW
Hematology
Dr. Parameswaran Hari, MD
|
|
Give Review
Parameswaran Hari is an expert in the field of Hematology. He researched medicine at Medical College of Wisconsin Affiliated Hospitals. He received awards:"Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Doctor Parameswaran Hari, MD has written publications. He has 91 publications published with PubMed. The lastest publication is: 'Morbidity and mortality attributable to Rothia bacteremia in neutropenic and nonneutropenic patients.' He accepts Medicare.
Publications
- Monocyte recovery at day 100 is associated with improved survival in multiple myeloma patients who undergo allogeneic hematopoietic Cell transplantation.
- Morbidity and mortality attributable to Rothia bacteremia in neutropenic and nonneutropenic patients.
- Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.
- Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups.
- Disparities in utilization of autologous hematopoietic Cell transplantation for treatment of multiple myeloma.
- New Cancers after autotransplantations for multiple myeloma.
- Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor Cells (HPC) in AL amyloidosis.
- Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor Cells in light chain amyloidosis.
- Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple my...
- Impact of Pre-transplant Therapy and Depth of Disease Response prior to Autologous Transplantation for Multiple Myeloma.
- Allogeneic hematopoietic Cell transplantation for mycosis fungoides and Sezary syndrome.
- Chronic GVHD and concurrent new-onset nephrotic syndrome in allogeneic transplant recipients. Incidence, pattern and therapeutic outcomes.
- A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.
- All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies.
- Early Failure of Frontline Rituximab-containing Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma does not Predict Futility of Autologous Hematopoietic Cell Transpla...
- Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation.
- Hematopoietic stem Cell transplantation in older persons: respecting the heterogeneity of age.
- Outcomes in patients with relapsed or refractory multiple Myeloma in a phase I study of everolimus in combination with lenalidomide.
- Lenalidomide Maintenance for High-Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation.
- Allogeneic hematopoietic cell transplant for Acute myeloid leukemia: Current state in 2013 and future directions.
- Incidence and outcomes of Clostridium difficile-associated Disease in hematopoietic cell transplant recipients.
- Reduced-intensity hematopoietic Cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow tran...
- Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation...
- Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
- Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin Lymphoma.
- Nanoliposomes protect against AL amyloid light chain protein-induced endothelial injury.
- Second transplants for multiple Myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantation.
- Clinical and imaging predictors of 1-year and long-term mortality in light chain (AL) amyloidosis: a 5-year follow-up study.
- Fludarabine and 2-Gy TBI is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial.
- Autologous haematopoietic cell transplantation for non-Hodgkin Lymphoma with secondary CNS involvement.
- Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma.
- Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma.
- Intermittent Zoledronic Acid Prevents Bone Loss in Adults after Allogeneic Hematopoietic Cell Transplantation.
- Divergent Effects of Novel Immunomodulatory Agents and Cyclophosphamide on the Risk of EnGraftment Syndrome after Autologous Peripheral Blood Stem Cell Transplantation...
- Is hematopoietic cell transplantation still a valid option for mantle cell Lymphoma in first remission in the chemoimmunotherapy-era?
- Graft-versus-host disease and Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.
- Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic Cell transplantation: prognostic relevance of the initial CD3+ T Cell ...
- Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III ...
- Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell Lymphoma: a cohort analysis from the center for international blood and marrow ...
- Salvage Second Hematopoietic Cell Transplantation in Myeloma.
- Multiple Myeloma: future directions in autologous transplantation and novel agents.
- Autologous and allogeneic transplantation for burkitt Lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transpl...
- Outcome of Lower-Intensity Allogeneic Transplantation in Non-Hodgkin Lymphoma after Autologous Transplantation Failure.
- Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin Lymphoma using lower intensity conditioning: a report from the CIBMTR.
- Percussion hemoglobinuria - a novel term for hand trauma-induced mechanical hemolysis: a case report.
- Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for Acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials...
- Trends in allogeneic stem Cell transplantation for multiple myeloma: a Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.
- Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell-Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in ...
- Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR Study.
- Access to hematopoietic stem Cell transplantation: effect of race and sex.
- Race and outcomes of autologous hematopoietic Cell transplantation for multiple myeloma.
- A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell Lymphoma: a report from the CIBMTR.
- Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell Lymphoma.
- Unrelated donor hematopoietic cell transplantation for non-hodgkin Lymphoma: long-term outcomes.
- Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin Lymphoma.
- Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's Macroglobulinemia.
- Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
- Vesicoureteric reflux and reflux nephropathy.
- Sustained hypertension in children.
- Performing and processing FNA of anterior fat pad for amyloid.
- Intraventricular dyssynchrony in light chain amyloidosis: a new mechanism of systolic dysfunction assessed by 3-dimensional echocardiography.
- Outcome of lupus nephritis in Indian children.
- Detection of amyloid in abdominal fat pad aspirates in early amyloidosis: Role of electron microscopy and Congo red stained Cell block sections.
- Case report: Delayed enhancement on cardiac MRI in a patient with multiple Myeloma without amyloidosis.
- Prognostic implication of late gadolinium enhancement on cardiac MRI in light chain (AL) amyloidosis on long term follow up.
- Left ventricular ejection time on echocardiography predicts long-term mortality in light chain amyloidosis.
- Effect of Obesity on Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
- Multiple Myeloma: charging toward a bright future.
- Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-Cell large granular lymphocytic leukaemia.
- CD200 expression in plasma Cell myeloma.
- Is the International Staging System superior to the Durie-Salmon staging System? A comparison in multiple myeloma patients undergoing autologous transplant.
- Autologous haemopoietic stem-Cell transplantation followed by allogeneic or autologous haemopoietic stem-Cell transplantation in patients with multiple myeloma (BMT CT...
- Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem Cell transplantation.
- NF-kappaB as a target for the prevention of Graft-versus-host disease: comparative efficacy of bortezomib and PS-1145.
- Second autologous stem cell transplantation for relapsed Lymphoma after a prior autologous transplant.
- Phenotyping studies of clonotypic B lymphocytes from patients with multiple Myeloma by flow cytometry.
- Comparison of twin and autologous transplants for multiple Myeloma.
- Allogeneic transplants in follicular lymphoma: higher risk of Disease progression after reduced-intensity compared to myeloablative conditioning.
- Cure of multiple Myeloma -- more hype, less reality.
- Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic Cell transplantation for advanced hematologic malignancies.
- Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple Myeloma: phase 1 results from the multicenter EVOLUTION study.
- Nonmyeloablative conditioning for relapsed follicular Lymphoma.
- Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem Cell transplantation.
- Tocilizumab for the treatment of steroid refractory Graft-versus-host disease.
- Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative alloGrafting.
- Utility of CD56 immunohistochemical studies in follow-up of plasma Cell myeloma.
- Severe autologous GVHD after hematopoietic progenitor Cell transplantation for multiple myeloma.
- New questions about transplantation in multiple Myeloma.
- Temporal discordance between graft-versus-Leukemia and graft-versus-host responses: a strategy for the separation of graft-versus-Leukemia/graft-versus-host reactivity?
- Immunophenotypic stability of sezary Cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapy.
Procedures Preformed
- Bone Marrow Transplant
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Oncology
- Hematology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Medical College of Wisconsin Affiliated Hospitals -
Lankenau Medical Center -
University of Kerala Medical College
Hospital
-
Froedtert Memorial Lutheran Hospital
Helpful Reviews
Similar Doctors
|
Gina M. Lewis, APNP |
|
Dr. Ehab Atallah, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Ajit B. Divgi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles A. Bomzer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Julie A. Panepinto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret M. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Camellia A. Eshoa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sean M. Marks, MD
This Doctor is OpenDoctor Recommended.
|